Amyris files for Chapter 11
12 August 2023
Synthetic biotechnology company Amyris commenced voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware. Amyris entities outside the US are not included in the proceedings. The concomitant restructuring is intended to improve the company’s cost structure, capital structure, and liquidity position while streamlining Amyris’ business... Read more →


